Evidence map›Paper›PMID 37339119›Full record

ArticlePLoS biology2023

A new human embryonic cell type associated with activity of young transposable elements allows definition of the inner cell mass.

Manvendra Singh, Aleksandra M Kondrashkina, Thomas J Widmann, Jose L Cortes, Vikas Bansal, Jichang Wang, Christine Römer, Marta Garcia-Canadas, Jose L Garcia-Perez, Laurence D Hurst and 1 more

Open access · goldAbstract read
In one paragraph

Article in PLoS biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
7.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Retrotransposons in embryogenesis and neurodevelopment.Biochemical Society transactions · 2024
    Review
  11. Article
  12. Review
  13. Article
  14. Endogenous retrovirus HERVH-derived lncRNAProceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  15. Article
  16. The Molecular Impacts of Retrotransposons in Development and Diseases.International journal of molecular sciences · 2023
    Review
  17. Article
  18. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 3 countries.

Manvendra SinghMax-Delbrück-Center for Molecular Medicine in the Helmholtz Society, Berlin, Germany.
Aleksandra M KondrashkinaMax-Delbrück-Center for Molecular Medicine in the Helmholtz Society, Berlin, Germany.
Thomas J WidmannGENYO, Centre for Genomics and Oncological Research: Pfizer/University of Granada/Andalusian Regional Government, PTS Granada, Granada, Spain.
Jose L CortesGENYO, Centre for Genomics and Oncological Research: Pfizer/University of Granada/Andalusian Regional Government, PTS Granada, Granada, Spain.
Vikas BansalGerman Center for Neurodegenerative Diseases, Tübingen, Germany.
Jichang WangMax-Delbrück-Center for Molecular Medicine in the Helmholtz Society, Berlin, Germany.
Christine RömerMax-Delbrück-Center for Molecular Medicine in the Helmholtz Society, Berlin, Germany.
Marta Garcia-CanadasGENYO, Centre for Genomics and Oncological Research: Pfizer/University of Granada/Andalusian Regional Government, PTS Granada, Granada, Spain.
Jose L Garcia-PerezGENYO, Centre for Genomics and Oncological Research: Pfizer/University of Granada/Andalusian Regional Government, PTS Granada, Granada, Spain.
Laurence D HurstThe Milner Centre for Evolution, Department of Life Sciences, University of Bath, Bath, United Kingdom.ORCID 0000-0002-1002-1054
Zsuzsanna IzsvákMax-Delbrück-Center for Molecular Medicine in the Helmholtz Society, Berlin, Germany.ORCID 0000-0002-2053-2384
Max Delbrück Center · DEPfizer-University of Granada-Junta de Andalucía Centre for Genomics and Oncological Research · ESGerman Center for Neurodegenerative Diseases · DEUniversity of Bath · GB

Funding

Howard Hughes Medical Institute IECS-55007420Wellcome Trust
6 · The paper itself

Abstract

There remains much that we do not understand about the earliest stages of human development. On a gross level, there is evidence for apoptosis, but the nature of the affected cell types is unknown. Perhaps most importantly, the inner cell mass (ICM), from which the foetus is derived and hence of interest in reproductive health and regenerative medicine, has proven hard to define. Here, we provide a multi-method analysis of the early human embryo to resolve these issues. Single-cell analysis (on multiple independent datasets), supported by embryo visualisation, uncovers a common previously uncharacterised class of cells lacking commitment markers that segregates after embryonic gene activation (EGA) and shortly after undergo apoptosis. The discovery of this cell type allows us to clearly define their viable ontogenetic sisters, these being the cells of the ICM. While ICM is characterised by the activity of an Old non-transposing endogenous retrovirus (HERVH) that acts to suppress Young transposable elements, the new cell type, by contrast, expresses transpositionally competent Young elements and DNA-damage response genes. As the Young elements are RetroElements and the cells are excluded from the developmental process, we dub these REject cells. With these and ICM being characterised by differential mobile element activities, the human embryo may be a "selection arena" in which one group of cells selectively die, while other less damaged cells persist.

Indexed as

BlastocystDNA Transposable ElementsEmbryo, MammalianHumansDNA Transposable Elements

Identifiers

PMID37339119
PMCPMC10281584
OpenAlexW4381328814

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.